Clinical trial · Interventional
Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy
Prophylactic Use of Filgrastim SD/01 In Patients With Hodgkin's Disease Receiving ABVD Chemotherapy
NCT00038558CI-TRIAL-00035557completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin Disease | Hodgkin Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Adriamycin | Drug | — | UNRESOLVED |
| Bleomycin | Drug | Bleomycin | ALIAS |
| DTIC | Drug | Dacarbazine | ALIAS |
| Filgrastim SD/01 | Drug | — | UNRESOLVED |
| Vinblastine | Drug | Vinblastine | ALIAS |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Filgrastim + ABVD Chemotherapy
- interventionNames
- Drug: Filgrastim SD/01
- Drug: Adriamycin
- Drug: Bleomycin
- Drug: Vinblastine
- Drug: DTIC
Primary outcomes (1)
- measure
- Number of Patients with Response to Prophylactic Filgrastim SD/01Chemotherapy
- timeFrame
- Following ABVD chemotherapy course
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
Show eligibility criteria text
INCLUSION: * Previously untreated Hodgkin's disease patients who are scheduled to receive standard ABVD chemo. * Histologically proven diagnosis of Hodgkin's disease of any type. * Bidimensionally measurable disease. * Signed informed consent. * Age \>/= 16 yrs. * Adequate bone marrow reserve (ANC\>1000/uL, Platelet \>100,000/uL. * LVEF\>/=50% by MUGA scan or echocardiogram. * Serum creatinine \<2mg/dL; serum bilirubin\<2mg/dL. EXCLUSION: * HIV positive. * Pregnant women and those of child bearing age who are not using adequate contraception. * Prior chemotherapy. * Severe pulmonary disease including COPD and asthma. * History of prior sensitivity to E.coli derived products.
References
Publications (0)
Data not yet available
No reference posted for this study.